Stockscreener 앱 받기
2.06
2.49%
0.05
전일 마감가:
$2.01
열려 있는:
$2
하루 거래량:
10,052
Relative Volume:
0.66
시가총액:
$23.84M
수익:
$3.35M
순이익/손실:
$86,000
주가수익비율:
133.77
EPS:
0.0154
순현금흐름:
$2.67M
1주 성능:
+0.49%
1개월 성능:
-2.83%
6개월 성능:
+0.49%
1년 성능:
+94.34%
1일 변동 폭
$1.99
$2.06
1주일 범위
$1.99
$2.08
52주 변동 폭
$1.03
$2.95
Therapeuticsmd Inc Stock (TXMD) Company Profile
명칭
Therapeuticsmd Inc
전화
561-961-1900
주소
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
2.06 | 23.84M | 3.35M | 86,000 | 2.67M | 0.0154 |
TAK
Takeda Pharmaceutical Co Adr
|
18.73 | 59.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.10 | 47.93B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.32 | 40.99B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
74.81 | 30.91B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
549.16 | 23.55B | 3.17B | 1.29B | 1.01B | 27.09 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-07 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2020-05-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-12-02 | 개시 | Guggenheim | Buy |
| 2019-10-17 | 개시 | H.C. Wainwright | Buy |
| 2019-04-30 | 재개 | Noble Capital Markets | Outperform |
| 2018-06-15 | 개시 | JP Morgan | Overweight |
| 2017-09-08 | 개시 | Morgan Stanley | Equal-Weight |
| 2017-07-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2017-05-09 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2016-11-22 | 재개 | Jefferies | Buy |
| 2016-11-22 | 개시 | Oppenheimer | Outperform |
| 2016-11-07 | 재개 | Guggenheim | Buy |
| 2016-04-04 | 개시 | Goldman | Buy |
| 2015-12-08 | 재확인 | Jefferies | Buy |
| 2015-12-08 | 재확인 | Stifel | Buy |
| 2015-09-21 | 재확인 | Jefferies | Buy |
| 2015-06-09 | 개시 | Guggenheim | Buy |
| 2014-07-08 | 개시 | FBR Capital | Outperform |
| 2014-04-17 | 재확인 | Noble Financial | Buy |
| 2014-01-28 | 재확인 | Noble Financial | Buy |
모두보기
Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
Therapeuticsmd Stock Price Forecast. Should You Buy TXMD? - StockInvest.us
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TXMD Q3 2023 Earnings: EPS Misses by 154.9% as Revenue Remains at ZeroEBITDA Margin Trends - vinanet.vn
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TherapeuticsMD (TXMD) Holds Steady at $2.22 as Traders Eye Tight Trading RangeLong Setup Ideas - vinanet.vn
TherapeuticsMD (TXMD) Holds Steady at $2.22 as Traders Eye Tight Trading RangeCombination Correction - dars.gov.et
TherapeuticsMD (TXMD) Holds Steady at $2.22 as Traders Eye Tight Trading RangeCup and Handle - careplusvn.com
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
THERAPEUTICSMD STOCK : BIG PRICE RECOVERY | TXMD STOCK Moon (nkL8YZ0GKj) - Mshale
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD (TXMD) Quarterly Figures: EPS Falls Short of Its Estimate under the Current Snapshot; Post-Earnings: The Stock Ends Up 0.49% in the Latest ReadingAnalyst Drop Coverage - vinanet.vn
TherapeuticsMD (TXMD) Quarterly Figures: EPS Falls Short of Its Estimate under the Current Snapshot; Post-Earnings: The Stock Ends Up 0.49% in the Latest ReadingPre-Announcement Alert - siam.in
TherapeuticsMD (TXMD) Quarterly Figures: EPS Falls Short of Its Estimate under the Current Snapshot; Post-Earnings: The Stock Ends Up 0.49% in the Latest ReadingGross Profit Margin - dars.gov.et
TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordHigh Volume Node - vinanet.vn
TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordKey Reversal Day - vinanet.vn
TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordSocial Sentiment - careplusvn.com
TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordADD Alert - dars.gov.et
TherapeuticsMD (TXMD) Range: Moves 0.49% Down to $2.05; the Current Price Sits Inside the Supplied Technical Range for the Current SessionLiquidity Order Flow - vinanet.vn
TherapeuticsMD (TXMD) Range: Moves 0.49% Down to $2.05; the Current Price Sits Inside the Supplied Technical Range for the Current SessionDealer Gamma - siam.in
TherapeuticsMD (TXMD) Range: Moves 0.49% Down to $2.05; the Current Price Sits Inside the Supplied Technical Range for the Current SessionVolume Spike Alerts - careplusvn.com
TherapeuticsMD (TXMD) Results Review: The EPS Result Is Below Expectation for This Review; Post-Earnings: The Stock Records a 1.48% Increase at the CloseSegment Revenue Breakdown - vinanet.vn
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD, Inc. Revenue Breakdown – NASDAQ:TXMD - TradingView
TherapeuticsMD (TXMD) Results Review: The EPS Result Is Below Expectation for This Review; Post-Earnings: The Stock Records a 1.48% Increase at the CloseInterim Report - careplusvn.com
TherapeuticsMD (TXMD) Results Review: The EPS Result Is Below Expectation for This Review; Post-Earnings: The Stock Records a 1.48% Increase at the CloseReturn On Equity - dars.gov.et
TherapeuticsMD(TXMD) Stock Options Chain | Quotes & News - Moomoo
TherapeuticsMD Company Profile & Introduction - Moomoo
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TherapeuticsMD, Inc. Revenue Breakdown – DUS:29TA - TradingView
ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView
TherapeuticsMD (TXMD) Holds Steady at $2.08 as Traders Eye Key Support and ResistanceBull Flag - vinanet.vn
TherapeuticsMD (TXMD) Holds Steady at $2.08 as Traders Eye Key Support and ResistanceLow Volatility Picks - dars.gov.et
TherapeuticsMD Q2 2026 License Revenue Drops 8.7% Year Over Year - clinicaltrialvanguard.com
TherapeuticsMD Q2 Net Income From Cont Ops US - Moomoo
Therapeuticsmd Inc (TXMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.59%
5.57%
자본화:
|
볼륨(24시간):